Results 141 to 150 of about 9,892 (240)

Tolvaptan pharmacokinetics and pharmacodynamics in adolescents with autosomal dominant polycystic kidney disease. [PDF]

Eur J Pediatr
Shoaf SE, Sikes K.
europepmc   +1 more source

Clinical trial on the pharmacokinetics, pharmacodynamics and safety of tolvaptan in healthy Chinese males: an open-label, single and multiple dosage, parallel group study. [PDF]

Front Pharmacol
Liu H, Liu T, Liu M, Zheng X, Zhong W, Zhao Q, Jiang J, Hu P, Li Y.   +8 more
europepmc   +1 more source

Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma [PDF]

, 2019
Niamh O’Connor-Byrne, Siobhán Glavey, Roxana Maria Tudor, Philip Murphy, Chris Thompson, John Quinn   +5 more
openalex   +1 more source

Structural insights into antagonist recognition by the vasopressin V2 receptor. [PDF]

Nat Commun
Zhang T, Liu H, You C, Zhang Y, Xu Y, Pan B, Wu C, Jin S, Yin YL, Wu K, Chen Y, Sun H, Si Y, Tan Y, Yin W, Xu HE, Guo D, Jiang Y.   +17 more
europepmc   +1 more source

Revisiting the Role of Tolvaptan in the Management of Hyponatraemia in Acute Heart Failure: Balancing Quality of Life and Cost With Tolvaptan Treatment. [PDF]

Cureus
Olaogun I, Young EE, Anyim OB.
europepmc   +1 more source

Improving care and outcomes of inpatients with syndrome of inappropriate antidiuresis (SIAD): a prospective intervention study of intensive endocrine input vs. routine care [PDF]

, 2016
Emmanouil Bagkeris, Helen Carr, Pierre Marc Bouloux, Ploutarchos Tzoulis   +3 more
core   +1 more source

Case Report: One case of pregnancy complicated by large cell neuroendocrine carcinoma of the cervix with syndrome of inappropriate secretion of antidiuretic hormone. [PDF]

Front Oncol
Dong C, Zhu B, Miao G, Zheng Z.
europepmc   +1 more source

The Role of Baseline Total Kidney Volume Growth Rate in Predicting Tolvaptan Efficacy for ADPKD Patients: A Feasibility Study [PDF]

Hreedi Dev, Zhongxiu Hu, Jon D. Blumenfeld, Arman Sharbatdaran, Yelynn Kim, Chenglin Zhu, Daniil Shimonov, James M. Chevalier, Stephanie Donahue, Alan Wu, Arindam RoyChoudhury, Xinzi He, Martin R. Prince   +12 more
openalex   +1 more source

Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Heart Failure and Chronic Kidney Disease [PDF]

, 2018
Kennosuke Yamashita, Wataru Igawa, Morio Ono, Takehiko Kido, Toshitaka Okabe, Myong Hwa Yamamoto, Kisaki Amemiya, Naoei Isomura, Masami Otsuka, Masahiko Ochiai   +9 more
openalex   +1 more source

Long-Term Effects of Tolvaptan Therapy on Total Kidney Volume and Renal Function in Patients with Autosomal Dominant Polycystic Kidney Disease: A Single-Center Experience. [PDF]

J Clin Med
Filiopoulos V, Kofotolios I, Vallianou K, Karavasilis E, Ntounas G, Melexopoulou C, Marinaki S.   +6 more
europepmc   +1 more source